EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
8.95
+0.60 (7.19%)
At close: Nov 22, 2024, 4:00 PM
9.08
+0.13 (1.45%)
After-hours: Nov 22, 2024, 6:19 PM EST
EyePoint Pharmaceuticals Market Cap
EyePoint Pharmaceuticals has a market cap or net worth of $627.93 million as of November 22, 2024. Its market cap has increased by 154.43% in one year.
Market Cap
627.93M
Enterprise Value
397.25M
1-Year Change
154.43%
Ranking
Category
Stock Price
$8.95
Market Cap Chart
Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $627.93M, an increase of 61.59%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 569.90M | -30.16% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 661.20M |
| Phathom Pharmaceuticals | 638.64M |
| OrthoPediatrics | 637.85M |
| Omeros | 632.23M |
| Simulations Plus | 628.50M |
| Mineralys Therapeutics | 621.61M |
| Oculis Holding AG | 619.11M |
| Altimmune | 617.36M |